CDKN2A and Barrett esophagus: ,53 Furthermore, many of the described mutations that characterize esophageal cancer, such as TP53 and CDKN2A, also occur in precursor lesions such as Barrett’s esophagus and high-grade dysplasia, lowering the specificity of ctDNA testing.54